Revance Therapeutics saw the highest growth of 1.99% in patent filings in June and 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Revance Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Revance Therapeutics has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 80% filings and 50% grants. The United States(US), Denmark(DK), and European Patent Office(EPO) patent Office are among the top ten patent offices where Revance Therapeutics is filings its patents. Among the top granted patent authorities, Revance Therapeutics has 50% of its grants in United States(US) and 50% in European Patent Office(EPO).
AbbVie could be the strongest competitor for Revance Therapeutics
In terms of grant share, Revance Therapeutics stands in third position among its competitors. AbbVie and Revance Therapeutics secured the top positions according to recent patent publication data.
Patents related to digital banking and fintech lead Revance Therapeutics's portfolio
Revance Therapeutics has the highest number of patents in digital banking followed by, fintech and digital payments. For digital banking, nearly 14% of patents were filed and no patents were granted in Q2 2024.
Payment services related patents lead Revance Therapeutics portfolio followed by online retail, and retail
Revance Therapeutics has highest number of patents in payment services followed by online retail, retail, ecommerce & online payments, and e-commerce.
For comprehensive analysis of Revance Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
